North Capital »

Amylyx Pharmaceuticals shares owned by North Capital

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by North Capital from 13F filings

Historical chart of North Capital investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by North Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by North Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.8k 501 13.59
2025-06-30 $3.2k 500 6.41
2025-03-31 $1.8k 500 3.54

More positions owned by North Capital

Spdr Series Trust Loomberg 1-3 Mo (BIL)
Dimensional Etf Trust S Core Eqt Mkt (DFAU)
Apple Om (AAPL)
Dimensional Etf Trust Ntl Core Eqt Mk (DFAI)
Dimensional Etf Trust Mgr Cre Eqt Mng (DFAE)
Spdr S&p 500 Etf Tr R Unit (SPY)
Vanguard Scottsdale Fds Hort Term Treas (VGSH)
Invesco Qqq Tr Nit Ser 1 (QQQ)
Vanguard Instl Index Ltra-short Trea (VGUS)
Microsoft Corp Om (MSFT)
Berkshire Hathaway Inc Del L B New (BRK.B)
Meta Platforms L A (META)
Ubs Ag London Branch Tracs Alerian M (AMUB)
Vanguard Star Fds G Tl Intl Stk F (VXUS)
Alphabet Ap Stk Cl A (GOOGL)

View all positions for North Capital

Top funds holding Amylyx Pharmaceuticals

FMR
Perceptive Advisors
BlackRock
Adage Capital Partners GP
TCG Crossover Management
Vanguard Group
Saturn V Capital Management
Commodore Capital
First Light Asset Management
Point72 Asset Management
Henderson Group
Driehaus Capital Management
Almitas Capital
Goldman Sachs Group
Paradigm Biocapital Advisors

View all funds holding Amylyx Pharmaceuticals